Conservative planning

Preventative Aesthetics Melbourne

Preventative aesthetics is one of the most common reasons people in their twenties and early thirties book a first consultation. The phrase suggests something straightforward: treat early, age more slowly. The clinical reality is more nuanced, and the conversation deserves more honesty than the marketing usually allows.

Quick summary

Preventative aesthetics describes a conservative, anatomy led approach to the first stages of an injectable treatment plan, focused on softening repetitive expression patterns before they etch into the skin as static lines. At Core Aesthetics, every preventative plan is individually assessed by Corey Anderson, Registered Nurse (AHPRA NMW0001047575), and the answer is sometimes that intervention is not yet appropriate. Results vary between people.

The most useful version of this conversation begins with a definition. Preventative aesthetics is not anti-ageing. It is not insurance. It is not a way of stopping time. It is a clinical decision to soften repeated muscular movement in defined facial regions before the skin overlying that movement loses the elasticity to recover between expressions. That is a narrower, more honest claim than most clinics make, and it is the one that holds up to clinical scrutiny.

Most people who arrive asking about prevention are between 25 and 35. They have noticed faint lines that appear with expression and remain for a moment after the face relaxes. They are wondering whether starting now is sensible, premature, or unnecessary. Those are good questions, and the only honest answer involves an in person assessment of skin quality, expression dynamics and personal history.

What the science actually supports

Skin lines form through a combination of repeated muscle contraction, declining dermal collagen and elastin, accumulated photodamage and gravitational change. Of these, only the muscular component is meaningfully addressed by neuromodulator treatment. The mechanism is well characterised: a small dose of prescription neuromodulator temporarily reduces signalling at the neuromuscular junction in selected facial muscles, producing reduced amplitude of expression. Over time, the skin overlying that muscle is creased less often and less deeply.

The published evidence supports softer dynamic lines and slower transition from dynamic to static lines, particularly in the glabellar complex (the muscles between the brows) and the forehead. The evidence does not support claims of permanent prevention, broad anti-ageing, or comprehensive skin quality improvement from injectable treatment alone. Pretending otherwise crosses into territory that AHPRA and the TGA explicitly regulate.

Static lines, dynamic lines, and the difference that matters

A dynamic line is a fold that appears when a muscle contracts and disappears when it relaxes. A static line is one that remains visible at rest, etched into the skin by years of identical creasing. The transition from dynamic to static is gradual and varies enormously between people. Genetics, sun exposure, sleep position, hydration and individual expression habits all contribute.

Conservative early treatment can lengthen the runway between dynamic and static. It cannot reverse static lines once they are established, although it can soften how they continue to deepen. People with established static lines often need a different conversation, sometimes involving skin treatments outside our scope, and that conversation begins with naming the limit clearly rather than promising what cannot be delivered.

Who genuinely benefits from early planning

The strongest indication for preventative neuromodulator treatment is a patient with strong expression dynamics in a defined region (often the glabella or lateral orbital area) where dynamic lines are appearing earlier than would be expected for age. A person who frowns deeply when concentrating, who spends long workdays at a screen, or who has inherited a particularly active corrugator pattern from a parent fits the picture.

The weaker indication is a patient who has read about prevention online and is anxious about ageing in the abstract. There may still be a place for treatment in that situation, but the conversation needs to start with what their face is actually doing, not with the catalogue of what other people their age are choosing.

When the answer is not yet

Some people who book a preventative consultation leave without a treatment plan. That is a clinical decision, not a sales failure. Common reasons we defer are minimal expression dynamics that do not warrant intervention, skin concerns better addressed by another modality, unrealistic expectations about what neuromodulator treatment can achieve, or a sense during consultation that the person is not yet certain about proceeding.

Deferring is part of a consultation based model. Returning in twelve or eighteen months, after thinking the decision through, is a reasonable next step. Treatment that is not clinically indicated today does not become more appropriate because the person has already taken time off work to attend.

The conservative dosing rationale

When preventative treatment is appropriate, the dose is smaller than would be used for established lines. The intent is to soften, not to immobilise. There are clinical reasons for this and patient experience reasons. Clinically, a lower dose preserves enough expression for the face to communicate normally and reduces the risk of over correction. From the patient side, a softer first treatment allows a two week review where dose can be adjusted upward if needed, rather than a fully loaded first dose that can only be waited out if too strong.

This approach (start lower, review at two weeks, adjust gradually) is a defining part of the C.O.R.E. Method and is particularly appropriate for first time and preventative patients. It is slower than single session, full dose treatment. It produces results that age more naturally because the face never moves through a phase of being obviously frozen.

What preventative aesthetics is not

Three claims commonly made about preventative treatment do not survive clinical scrutiny and we do not make them.

The first is that early treatment ensures a younger appearance later. Ageing is multifactorial and continues regardless of muscular dampening in selected regions. The second is that starting in your twenties means you will need less treatment in your forties. There is some clinical observation supporting this for selected muscles, but the data is not strong enough to claim it. The third is that preventative treatment is a substitute for skin care, sun protection, sleep and lifestyle choices that do measurably influence how skin ages. It is not. It is one component, in selected people, in selected regions.

The Melbourne context

Australian sun exposure is the single largest controllable contributor to how facial skin ages. Melbourne residents who spend any meaningful time outdoors are dealing with UV indices that exceed those of most northern hemisphere cities for substantial parts of the year. Sun protection in childhood and across early adulthood does more for long term skin quality than most cosmetic interventions.

This matters for the preventative conversation because a person with significant accumulated photodamage often has skin issues that injectable treatment alone cannot address. Identifying that early lets us point towards dermatological care, medical grade topical strategies, or the simple discipline of daily SPF before pursuing injectable treatment that would otherwise produce a disappointing result.

Patients in their twenties: the over-treatment risk

The genuine risk in younger preventative work is over-treatment. A 26-year old with active expression dynamics who is treated to full immobilisation looks young in repose and unfamiliar in motion. Expression flattening at this age tends to read as conspicuous in social contexts where peers have unmodified faces, and it is the most common form of regret expressed by patients in this age group.

The avoidable form of this regret is conservative dosing with structured review. The unavoidable form is patients who arrive having already received aggressive treatment elsewhere and want to know how to recover natural expression. The honest answer is usually time. Neuromodulator effect attenuates over months, and a patient can use that interval to recalibrate what they actually want their face to do.

Patients in their thirties: the planning conversation changes

By the mid thirties, dynamic lines in the glabellar complex and around the lateral orbits often begin transitioning to mild static lines. The clinical conversation here is different. We are no longer purely preventative. We are working in the early static phase, where soft, well placed treatment can prevent further deepening while skin and underlying support are still able to recover between treatments.

This phase rewards a structured review rhythm rather than a single session approach. Treatment intervals of three to four months, reviewed each time against actual line behaviour, tend to produce better long term outcomes than longer intervals where lines have already begun re etching before the next dose. Intervals shorter than this rarely add benefit and can contribute to muscle atrophy that reads as gaunt rather than refreshed.

How the consultation actually runs

A preventative consultation at Core Aesthetics begins with a conversation, not an examination. We want to understand what brought the person in, what they have read or been told, what their non negotiable concerns are, and what they would consider an over correction. Then we move to anatomical assessment of expression dynamics in repose and in animation, photographed under standardised conditions for the medical record.

If a treatment plan is appropriate, we discuss it in plain language with the dose range, the muscles involved, the realistic two week response, the recommended review interval and the anticipated cost across the first twelve months. There is no pressure to proceed in the same session. Many patients return for treatment days or weeks after the initial consultation, having considered the plan in their own time.

AHPRA September 2025 and what changed for younger patients

The AHPRA guidelines for nonsurgical cosmetic procedures that came into force in September 2025 introduced specific protections relevant to preventative treatment. For any patient under 18, a mandatory seven day cooling off period now applies between consent and treatment, and payment cannot be accepted before the cooling off period has elapsed. We do not treat patients under 18 except in specific clinical circumstances that do not apply to preventative aesthetics.

The same guidelines also tightened the requirements for assessing patient suitability across all age groups. Practitioners must explicitly discuss reasons and motivations, and prescribers must conduct an in person or video consultation each time they prescribe a cosmetic injectable. Asynchronous prescribing by text or online is no longer acceptable. These protections raise the floor of what counts as appropriate practice in this field.

What we do not advertise (and why it matters here)

Australian regulation prohibits the advertising of Schedule 4 prescription medicines to the public. That includes the brand names, abbreviations, hashtags and nicknames associated with cosmetic injectable products. You will not find brand name comparisons or product endorsements in our content because the law explicitly prohibits them. The TGA has been increasingly active in enforcement of this provision, and clinics that work around it tend to be the same clinics that work around other clinical and ethical limits.

For a patient considering preventative treatment, this matters because it filters the clinics where careful comparison shopping is possible. We can talk in detail about the class of treatment, the mechanism, the expected response, the dose ranges and the safety considerations. The conversation is more substantive when it is anchored in clinical fact rather than product marketing.

Working with Corey

Corey Anderson is the only practitioner at Core Aesthetics. Registered with the Nursing and Midwifery Board of Australia since January 1996 (AHPRA NMW0001047575), Corey has built a one practitioner, low volume clinic in Oakleigh specifically because that model supports the kind of unhurried, conservative planning that preventative work requires. Patients see the same clinician at every visit, and the treatment record carries forward in continuous detail across years.

This is a deliberate counterweight to the clinic models where injectors rotate through and consistency over time becomes impossible. For preventative aesthetics, where the value lies in slow accumulation of small adjustments, continuity of clinician is not a marketing line. It is part of the clinical method.

A note on terminology

The phrase preventative aesthetics is sometimes used loosely to cover everything from injectable treatment to topical skin care to in clinic device work. At Core Aesthetics our scope is specifically injectable. We do not provide skin treatments, energy devices or topical product retailing, and where the conversation indicates that another modality would serve a patient better than an injectable approach we say so plainly. That sometimes means we are not the right clinic for a particular goal, and we would rather have that conversation honestly than try to fit the goal to what we can offer.

It is also worth being precise about what is being prevented. We are not preventing the passage of time, the influence of inherited anatomy or the cumulative effect of decades of expression. We are softening selected dynamic patterns where the clinical assessment supports doing so, with the smallest dose that produces the desired softening, reviewed at regular intervals against actual line behaviour rather than against an idealised plan written on day one.

Why this conversation matters more in 2026

The cosmetic injectables sector in Australia has changed substantially in the last twenty four months. Tighter AHPRA practice guidelines, sharper TGA enforcement of the advertising provisions and rising patient awareness of what conservative practice actually looks like have raised expectations of clinics. The patients who arrive for a preventative consultation today are usually better informed, more sceptical of marketing claims and more interested in the underlying clinical reasoning than they were five years ago.

That is a positive shift, and it shapes how this consultation runs. Patients who want to understand the mechanism of treatment, the limits of preventative work and the realistic timeline tend to ask sharper questions and reach better long term decisions. The role of the practitioner is to give substantive answers, to explain what the evidence does and does not support, and to be willing to say that an intervention is not appropriate when that is the clinical reality.

Booking a consultation

Consultations at Core Aesthetics are individually scheduled and booked directly online or by contacting the clinic. The consultation is a clinical assessment and a conversation, not a treatment commitment. If the assessment is that no treatment is yet indicated, the consultation closes there. If treatment is appropriate, planning happens in the same session and treatment can be scheduled at a time the patient chooses.

Core Aesthetics operates from 12A Atherton Road, Oakleigh, in Melbourne’s south east. The clinic is straightforward to reach from across the south east corridor, the bayside strip and the inner east. Results vary between individuals, and any treatment plan is built around the specific anatomy and goals of the person in front of us, not the catalogue of what is selling well that month.

Where The Phrase Comes From And Why It Is Often Used Carelessly

The phrase ‘preventative aesthetics’ entered cosmetic injectable practice in the early 2010s, originally as a clinical shorthand for treating dynamic lines before they had become static. The clinical reasoning was reasonable: a line that is repeatedly etched into the skin by chronic muscle contraction tends to deepen over years, and reducing the contraction reduces the etching. Whether the visible adult onset of static lines is meaningfully delayed by treatment that begins ten years earlier than it otherwise would have, in patients who would not have developed problematic lines at the same rate without it, is a question the clinical literature has not resolved with high confidence.

The phrase has since been pulled towards marketing use, where it tends to imply a stronger evidence base than the literature supports. Patients in their early twenties are sometimes told that beginning treatment now will spare them visible ageing changes in their thirties and forties. The honest framing is more modest: early intervention has a plausible role in patients with strong dynamic line activity who can demonstrate a clear pattern of etching at a young age, and a much weaker role in patients whose facial movement is unremarkable. The decision belongs in the consultation rather than in a generic recommendation by age band.

The clinic operates by Corey Anderson, Registered Nurse, AHPRA NMW0001047575, and the consultation conversation about preventative aesthetics is structured to identify which group an individual patient falls into. Patients sometimes arrive convinced they need treatment because of how the phrase has been used in their social or media environment; the consultation often concludes that they do not, that they would benefit more from a structured skin care and sun protection plan, and that the cosmetic injectable conversation can be revisited in twelve to twenty four months if circumstances change.

The financial framing also matters. A continuous preventative treatment plan begun in the mid twenties and maintained for thirty years involves substantial cumulative cost across many cycles, with no equivalent durability assurance. Patients who proceed should do so with a clear sense of the long term commitment involved, and patients who defer are not making a worse decision; they are making a different one. The consultation provides the conversation, not the obligation.

How To Document A Preventative Plan So It Remains Useful Across Years

Preventative aesthetics planning is most valuable when it is documented in a way that supports decisions across years rather than across single appointments. The treatment record at Core Aesthetics consultations includes baseline photographs taken under standardised lighting, the dose and area of each treatment, the patient’s reported response, and any observations the practitioner records about emerging changes that warrant attention at subsequent appointments. The documentation accumulates into a record that informs the assessment more accurately than memory or self report would. Patients who have been treated continuously for several years often find that reviewing the documented record together at a later consultation surfaces patterns that were not visible from any single appointment.

Is this for you?

Consider booking a consultation if

  • You are in your late twenties, thirties or early forties and have noticed dynamic expression lines starting to persist briefly after the face relaxes
  • You want a conservative, low dose first treatment with a structured two week review rather than a single high dose session
  • You are willing to defer treatment if the consultation determines it is not yet clinically indicated
  • You value continuity with a single registered clinician across years of small, incremental planning

This may not be for you if

  • You are pregnant, trying to conceive, or breastfeeding
  • You have an active skin infection or unhealed skin in a potential treatment area
  • You have a neuromuscular condition that contraindicates neuromodulator treatment, or a known allergy to its components
  • You are under 18 (we do not provide preventative aesthetics treatment to minors)
  • You are seeking same day treatment without a prior in person consultation

Suitability is confirmed at consultation. This list is general guidance, not a substitute for clinical assessment.

Frequently asked questions

What age is appropriate to consider preventative aesthetics?

There is no single appropriate age. The clinical question is whether the person’s expression dynamics are producing dynamic lines that are starting to persist briefly after the face relaxes. That can occur as early as the mid twenties in patients with strong expression habits or genetic predisposition, or not until the mid thirties in others. The right age is the age at which an in person assessment finds an indication, not the age at which a friend started.

Does preventative neuromodulator treatment actually slow facial ageing?

It can slow the deepening of dynamic expression lines in the specific muscles treated. It does not slow facial ageing more broadly. Bone resorption, fat pad redistribution, sun driven dermal change and gravitational descent continue regardless of neuromodulator treatment. Anyone claiming that early injectable treatment prevents ageing in any general sense is overstating what the published evidence supports.

What happens if I start treatment early and then stop?

Neuromodulator effect attenuates over months and the muscle returns to its previous activity. The lines that were softened during treatment will gradually become more visible again. There is no rebound effect that makes lines worse than they would have been without treatment, and no dependency in the pharmacological sense. Stopping is straightforward and reversible.

How is preventative dosing different from standard treatment?

Preventative dosing is typically lower per muscle and may treat fewer regions than a standard plan. The intent is softening rather than immobilisation, with enough remaining expression to allow normal communication. A two week review is built in so dose can be adjusted upward if the response is not strong enough, rather than starting at a higher dose that can only be waited out if too strong.

Is there a risk of muscle atrophy from long term preventative treatment?

Some reduction in muscle bulk is expected with sustained treatment over years and is part of why long treated muscles often need slightly lower doses than they did initially. This is generally cosmetically favourable in most facial muscles. Where it becomes a concern, dose intervals can be lengthened or treatment can be paused. This is monitored through the structured review process.

How does AHPRA’s September 2025 guideline affect a preventative consultation?

For most adults considering preventative aesthetics, the practical change is that any prescription must follow an in person or video consultation with the prescribing practitioner each time, rather than being arranged asynchronously. Suitability assessment must explicitly explore motivations. For anyone under 18 there is now a mandatory seven day cooling off period and a prohibition on accepting payment before that period elapses, but Core Aesthetics does not treat patients under 18 for preventative aesthetics.

How long does a first preventative consultation take?

Allow about an hour. The first portion is conversation about goals, history and reasons for considering treatment. The second is anatomical assessment in repose and in animation, with standardised photography for the medical record. If treatment is appropriate, the planning discussion happens in the same session and treatment can be scheduled at a time the patient chooses. There is no obligation to proceed in the same visit.

What does Core Aesthetics not do that some clinics do?

We do not run promotional pricing or time limited offers, we do not name or compare prescription products, we do not provide before and after gallery imagery of identifiable patients, and we do not treat patients without a structured prior consultation. Some of these restrictions are explicit in AHPRA and TGA regulation. Others are clinical and ethical choices that distinguish a consultation based practice from a sales led one.

Clinical references

  1. TGA: Regulation of cosmetic injectables in Australia
  2. AHPRA: Guidelines for registered health practitioners in cosmetic procedures
  3. ACCSM: Public information for patients

Written and reviewed by Corey Anderson RN, AHPRA NMW0001047575 · Reviewed April 2026 · Consultation required · TGA & AHPRA compliant

Ready When You Are

Start with a conversation.

No commitment required. Book a consultation or send a message, Corey will respond personally.

Book a Consultation

Corey Anderson RN AHPRA NMW0001047575 Registered since 1996 Oakleigh, Melbourne